Halozyme Therapeutics, Inc. (HALO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 09:56AM EDT. Market open.
| Previous close | 39.12 |
| Open | 38.71 |
| Bid | 38.28 x 200 |
| Ask | 38.47 x 200 |
| Day's range | 38.25 - 38.73 |
| 52-week range | 29.85 - 45.00 |
| Volume | |
| Avg. volume | 1,031,303 |
| Market cap | 4.876B |
| Beta (5Y monthly) | 1.25 |
| PE ratio (TTM) | 18.27 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- Zacks
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- Zacks
Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why
Halozyme Therapeutics (HALO) could produce exceptional returns because of its solid growth attributes.
© 2024 Yahoo. All rights reserved.